InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Discover the complete record of transactions filed by Ribeiro Ramiro. Director active across 2 companies, notably EyePoint, Inc.. Cumulatively, 7 disclosures have been logged. Breakdown: 0 buy · 2 sells. Total volume traded: €58k. History available since 11 November 2025. The latest transaction was disclosed on 17 April 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Ribeiro Ramiro is a declarant linked to EyePoint, Inc. and EyePoint Pharmaceuticals, Inc., where he is Chief Medical Officer. He has 7 filings in total, and across the sampled recent filings from 2025-11-12 to 2026-04-20, sales total 58369 EUR, with the transaction nature listed as Option exercise.